Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jul 2009 The Team Approach to Management of the Polytrauma Patient Stephen C. Morris, MD A highly coordinated team effort stabilizes and manages victims of polytrauma. Virtual Mentor. 2009;11(7):516-520. doi: 10.1001/virtualmentor.2009.11.7.cprl1-0907. State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3
State of the Art and Science Jul 2009 The Team Approach to Management of the Polytrauma Patient Stephen C. Morris, MD A highly coordinated team effort stabilizes and manages victims of polytrauma. Virtual Mentor. 2009;11(7):516-520. doi: 10.1001/virtualmentor.2009.11.7.cprl1-0907.
State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.